<?xml version="1.0" encoding="utf-8"?> <rss version="2.0" xml:base="https://www.mobihealthnews.com" xmlns:dc="http://purl.org/dc/elements/1.1/"> <channel> <title>MobiHealthNews - DenovAI</title> <link>https://www.mobihealthnews.com/tag/denovai</link> <description></description> <language>en</language> <item> <title>AION Labs launches second startup focused on AI-enabled antibody design</title> <link>https://www.mobihealthnews.com/news/aion-labs-launches-second-startup-focused-ai-enabled-antibody-design</link> <description><div class="field field-name-body field-type-text-with-summary field-label-hidden"><div class="field-items"><div class="field-item even" property="content:encoded"><p dir="ltr"><span id="docs-internal-guid-7da60396-7fff-bcc2-b2ca-08ea30e3c729">Israel-based </span><a href="https://www.mobihealthnews.com/tag/aion-labs" target="_blank">AION Labs</a>, an AI-enabled drug discovery partnership between global pharma and tech companies, announced the launch of its second startup, DenovAI.</p> <p dir="ltr"><span id="docs-internal-guid-7da60396-7fff-bcc2-b2ca-08ea30e3c729">DenovAI will develop an AI-enabled computational biophysics platform that can discover potential antibodies directed toward specific epitopes (the part of an antigen molecule recognized by the immune system to which an antibody attaches itself). The company said the platform will design antibodies from scratch, then suggest which candidates will likely make effective drugs. </span></p> <p dir="ltr"><span id="docs-internal-guid-7da60396-7fff-bcc2-b2ca-08ea30e3c729">AION Labs was built under a government tender and includes pharma giants AstraZeneca, Merck, Pfizer and Teva, alongside venture capital firm Israel Biotech Fund, strategic partner Amazon Web Services and German independent research institute Bio Med X.</span></p> <p dir="ltr"><span id="docs-internal-guid-7da60396-7fff-bcc2-b2ca-08ea30e3c729">Funding and pharmaceutical data for machine learning development and model training will be provided to DenovAI by AION Labs. </span></p> <p dir="ltr"><span id="docs-internal-guid-7da60396-7fff-bcc2-b2ca-08ea30e3c729">"We have seen major advances in the field of therapeutic antibodies, but the process of developing new drugs is incredibly slow, vastly expensive and inefficient. With the support of AION Labs and its partners, we hope to develop a cutting-edge solution that will disrupt the whole field, cutting discovery timelines from months to days. And which could dramatically broaden the scope of antibody therapy to many more diseases," Dr. Kashif Sadiq, founder and CEO of DenovAI, said in a statement.</span></p> <p dir="ltr"><strong><span id="docs-internal-guid-7da60396-7fff-bcc2-b2ca-08ea30e3c729">THE LARGER TREND</span></strong></p> <p dir="ltr"><span id="docs-internal-guid-7da60396-7fff-bcc2-b2ca-08ea30e3c729">AION Labs announced its first startup last year, dubbed </span><a href="https://www.mobihealthnews.com/tag/omecai" target="_blank">OMEC.AI</a>, which aims to build an AI-enabled computational platform to help researchers assess the clinical trial readiness of a drug candidate, identify hidden safety liabilities and suggest experiments to close any identified gaps. </p> <p dir="ltr"><span id="docs-internal-guid-7da60396-7fff-bcc2-b2ca-08ea30e3c729">"What we're trying to achieve at AION Labs in general … is creating great independent-growth AI-based startups for the biotech field so we can help scientists and researchers — not to replace them, but to really empower them by bringing new technological capability so that they can optimize the whole process of drug discovery and development," </span><a href="https://www.mobihealthnews.com/news/qa-aion-labs-new-startup-aims-streamline-drug-discovery-process" target="_blank">Mati Gil, CEO of AION Labs</a>, told <em>MobiHealthNews</em> in September.</p> <p dir="ltr"><span id="docs-internal-guid-7da60396-7fff-bcc2-b2ca-08ea30e3c729">Other companies utilizing AI tools for drug discovery include drug research platform </span><a href="https://www.mobihealthnews.com/news/tech-enabled-drug-discovery-startup-insilico-medicine-lands-225-million" target="_blank">Insilico Medicine</a> and UK-based health tech firm <a href="https://www.mobihealthnews.com/tag/healx" target="_blank">Healx</a>, which uses AI to accelerate drug discovery and treatments for rare diseases. </p> <div style="position: relative; display: block; max-width: 100%;"> <div style="padding-top: 56.25%;"> <iframe allow="encrypted-media" allowfullscreen="" src="https://players.brightcove.net/1824526989001/default_default/index.html?videoId=6319481774112" style="position: absolute; top: 0px; right: 0px; bottom: 0px; left: 0px; width: 100%; height: 100%;"></iframe></div> </div> </div></div></div> <!-- THEME DEBUG --> <!-- CALL: theme('paragraphs_items') --> <!-- FILE NAME SUGGESTIONS: * paragraphs-items--field-enterprise-taxonomy--full.tpl.php * paragraphs-items--field-enterprise-taxonomy.tpl.php x paragraphs-items.tpl.php --> <!-- BEGIN OUTPUT from 'sites/all/modules/contrib/paragraphs/theme/paragraphs-items.tpl.php' --> <div class="paragraphs-items paragraphs-items-field-enterprise-taxonomy paragraphs-items-field-enterprise-taxonomy-full paragraphs-items-full"> <div class="label-above">Enterprise Taxonomy:&nbsp;</div> <!-- THEME DEBUG --> <!-- CALL: theme('entity') --> <!-- FILE NAME SUGGESTIONS: * ds-reset--paragraphs-item--20272.tpl.php * ds-reset--paragraphs-item-enterprise-taxonomy-full.tpl.php * ds-reset--paragraphs-item-enterprise-taxonomy.tpl.php * ds-reset--paragraphs-item-full.tpl.php * ds-reset--paragraphs-item.tpl.php x ds-reset.tpl.php * paragraphs-item--20272.tpl.php * paragraphs-item--enterprise-taxonomy--full.tpl.php * paragraphs-item--enterprise-taxonomy.tpl.php * paragraphs-item.tpl.php * entity.tpl.php --> <!-- BEGIN OUTPUT from 'sites/all/modules/contrib/ds/layouts/ds_reset/ds-reset.tpl.php' --> <div class="field field-name-enterprise-taxonomy-primary-topic field-type-ds field-label-hidden"><div class="field-items"><div class="field-item even"><div class="field field-name-enterprise-taxonomy-topic field-type-entityreference field-label-hidden"><div class="field-items"><div class="field-item even"><a href="/topics/pharma">Pharma</a></div></div></div></div></div></div> <!-- END OUTPUT from 'sites/all/modules/contrib/ds/layouts/ds_reset/ds-reset.tpl.php' --> </div> <!-- END OUTPUT from 'sites/all/modules/contrib/paragraphs/theme/paragraphs-items.tpl.php' --> </description> <pubDate>Tue, 28 Feb 2023 19:15:41 +0000</pubDate> <dc:creator>JHagen</dc:creator> <guid isPermaLink="false">152770 at https://www.mobihealthnews.com</guid> <comments>https://www.mobihealthnews.com/news/aion-labs-launches-second-startup-focused-ai-enabled-antibody-design#comments</comments> </item> </channel> </rss>